About This Conference
The annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS) meeting is recognized as one of the premier multi-tumor oncology/hematology meetings worldwide. Now in its fifth decade, this unique oncology educational event attracts an audience of over 2,000 oncology professionals to discuss the cutting-edge advances in cancer therapy across solid and hematologic malignancies and share ideas with their peers.
Advances continue to rapidly occur at a staggering and unprecedented pace in virtually all aspects of cancer care, including diagnosis, treatment, and personalized management. Paradigm-shifting therapies over the years have altered entire methods by which tumors are managed, including the incorporation of systemic therapies, molecular targeted therapies, immunotherapies, and other biotechnological strategies into patient care. This progress in contemporary therapies, along with promising ongoing research, is ultimately hoped to vastly improve outcomes in many tumors, some of which have historically had poor prognoses. The annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS) meeting abides by the principle that the study of the latest scientific advances, with a focus on an educational agenda that reflects clinical trial data with the potential to impact cancer treatment, will improve outcomes for patients by assuring attendees leave the meeting understanding the most groundbreaking clinical research and treatment advances for the tumors they manage.
The annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS) is a premiere solid and liquid tumor forum for oncologists, hematologists, radiation oncologists, immunologists, oncology nurses, nurse practitioners, physician assistants, pharmacists, and case managers. At the 33rd Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS), our outstanding faculty of leading clinical innovators in virtually every tumor subspecialty will continue to provide expert insights on new developments in cancer therapeutics, and provide oncology professionals with the opportunity to learn about new compounds, novel approaches to diagnosis and treatment with currently available agents, ongoing clinical trials, and emerging developments that define current progress aimed at the goal of control and cure of cancer.
November 9-11, 2016
New York Marriott Marquis
New York, NY 10036
This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists interested in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other health care professionals interested in the treatment of cancer are also invited to attend.
The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is wholly owned and operated by PER Events, LLC, an affiliate of Physicians' Education Resource® and co-sponsored by Pharmacy Times Continuing Education (PTCE).